A Randomized, Subject and Investigator-Blind, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Intravenously Administered Doses of PD-0360324 in Patients With Rheumatoid Arthritis Receiving Methotrexate.
Phase of Trial: Phase I
Latest Information Update: 15 Jul 2009
At a glance
- Drugs PD 360324 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 15 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Jul 2009 Actual patient number (78) added as reported by ClinicalTrials.gov.
- 06 May 2009 Additional location (Mexico) identified as reported by ClinicalTrials.gov.